News

Find News

Filter articles

Showing 31 to 40 of 2541 results

Eli Lilly secures exclusive rights to chronic pain treatment

US03-06-2019

American pharmaceutical company Eli Lilly has secured an exclusive licence for a non-opioid, non-addictive chronic pain treatment from Boston-based biotech company Centrexion Therapeutics.

University of California settles licensing dispute with professor

US31-05-2019

The University of California has settled a dispute over the use of a diagnostic tool in graduate research projects.

Boehringer teams up with Gubra to develop second obesity treatment

Denmark, Germany30-05-2019

German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.

Celgene takes action against alleged cybersquatter

US30-05-2019

US biotechnology company Celgene has taken legal action against the registrant of a domain name which allegedly infringes Celgene’s trademarks.

Sensorion in gene therapy collaboration with Institut Pasteur

France29-05-2019

Biopharmaceutical company Sensorion has entered into a research collaboration with French research body Institut Pasteur.

BGI takes Illumina to court over patent infringement in US

Denmark, Germany, US29-05-2019

A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.

GSK settles TM suit over dry-mouth product

US28-05-2019

GSK has entered into a settlement agreement with California-based Laclede, ending a trademark infringement dispute between the pair.

University of California granted fifth CRISPR patent

US28-05-2019

The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier.

CMA accuses 4 pharma companies of anti-competitive conduct

UK24-05-2019

Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.

‘Considerable increase’ in pay-for-delay settlements: FTC report

US24-05-2019

The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013.

Showing 31 to 40 of 2541 results

LSIPR